A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL) or Acute Myeloid Leukemia (AML)Matthew S. Davids,Yesid Alvarado Valero,Catherine Diefenbach,Daniel N. Egan,Shira N. Dinner,Monzr M. Al Malki,Kebede Begna,Avyakta Kallam,Sameem Abedin,Rachel Cook,Nathalie Javidi-Sharifi,Edward Dominguez, Lu Miao,Richard G. Ghalie,Alexey DanilovBlood（2023）引用 0|浏览36暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
